What cost Rs 100 on September 21 across countries, is now up by Rs...
Category:
Facts
Latest
FACTBOX-How many people might die, and why, if China loosens COVID restrictions
China could see 1.3 million to 2.1 million people die if it lifts...
Many persons with disabilities face premature death due to health inequities
“It's a significant reason for these early deaths because of poor...
Legal drinking age lowered to 21 from 25 years in Delhi
The government announced that no new liquor shops will be opened and 60 per cent share of government shops in the current retail liquor business will be replaced by private players.
AstraZeneca says US trial data shows vaccine 79% effective
While the AstraZeneca vaccine has been authorized in more than 50 countries worldwide, scientists have been awaiting results of the U.S. study in hopes it will clear up some of the confusion about just how well the shots really work
Londoners hit by ‘staggering’ drop in life expectancy due to Covid-19
Analysis by the King’s Fund health think-tank saw the biggest falls in life expectancy in London, from 81.3 to 78.8 for men and 85 to 83.4 for women. They said it was worse than any fall since the Second World War, according to the Evening Standard.
Worrying decline in health of Gen X, Y in US: Study
The researchers showed that compared to previous generations, members of Generation X and Generation Y showed poorer physical health, higher levels of unhealthy behaviour such as alcohol use and smoking, and more depression and anxiety.
According to the lead researcher, Hui Zheng from The Ohio State University, the results suggest the likelihood of higher levels of diseases and more deaths in younger generations than seen in the past.
“The worsening health profiles we found in Gen X and Gen Y is alarming,” Zheng said.
Covid vaccine should be able to give protection for 8-10 months: AIIMS director
“The Covid-19 vaccine should be able to give good protection from the infection for eight to ten months and maybe, even more,” Guleria said at an event organised by the IPS (Central) Association.
Study discovers crucial step in formation of deadly brain diseases
The research concerned prion diseases- a group of brain diseases caused by proteins called prions that malfunction and ‘misfold’, turning into a form that can accumulate and kill brain cells. These diseases can take decades to manifest but are then aggressive and fatal.
They include Kuru, mad cow disease and its human equivalent Creutzfeldt-Jakob disease (CJD), and a heritable condition called fatal familial insomnia.
Cancer survivors face elevated heart disease risk: Study
“We know that obesity, cancer and cardiovascular disease share some common risk factors, and in addition to those shared risk factors, cancer patients also receive treatments including radiation and chemotherapy that can affect their cardiovascular health — we call that cardiotoxicity,” said lead researcher Xiaochen Zhang from The Ohio State University.
First known baby born with antibodies after mother vaccinated: Doctors
According to the yet-to-be peer-reviewed study, posted in the preprint server medRxiv, the mother had received a single dose of the Moderna mRNA vaccine at 36 weeks and three days of her gestation period.
Three weeks later, she gave birth to a vigorous, healthy, full-term girl, whose blood sample taken immediately after birth revealed the presence of antibodies against the SARS-CoV-2 virus, the study noted.
COVID-19 patients above 65 years of age more prone to reinfection, says study
“Our study confirms what a number of others appeared to suggest — reinfection with COVID-19 is rare in younger, healthy people, but the elderly are at greater risk of catching it again,” said study co-author Steen Ethelberg, from the Statens Serum Institut.
“Since older people are also more likely to experience severe disease symptoms, and sadly die, our findings make clear how important it is to implement policies to protect the elderly during the pandemic,” Ethelberg said.
Scientist behind coronavirus shot says next target is Cancer
“We have several different cancer vaccines based on mRNA,” said Tureci, who is BioNTech’s chief medical officer.
Asked when such a therapy might be available, Tureci said “that’s very difficult to predict in innovative development. But we expect that within only a couple of years, we will also have our vaccines (against) cancer at a place where we can offer them to people.”